cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
about
Hypoxic Vasodilation by Red Blood Cells: Evidence for an S-Nitrosothiol-Based SignalApolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular diseaseS-nitrosylation in cardiovascular signalingOverview of Antagonists Used for Determining the Mechanisms of Action Employed by Potential Vasodilators with Their Suggested Signaling PathwaysNitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic PropertiesRoles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprussideNCX 4016, a nitric oxide-releasing aspirin, modulates adrenergic vasoconstriction in the perfused rat tail arteryTherapeutic effects of nitric oxide-aspirin hybrid drugsPharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesiaNitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular systemRole of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivityInvolvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischaemiaA human platelet calcium calculator trained by pairwise agonist scanningCarbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genesCollagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cellsCarbon monoxide is the heme oxygenase product with a pyretic action: evidence for a cGMP signaling pathway.Oxidative risk for atherothrombotic cardiovascular disease.Cyclic GMP phosphodiesterase-5: target of sildenafil.Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall.Regulation of platelet granule exocytosis by S-nitrosylation.Nitric oxide and the liver.The mechanisms for nitration and nitrotyrosine formation in vitro and in vivo: impact of diet.Mechanisms of acute brain injury after subarachnoid hemorrhage.Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.Parallel pathways mediate inhibitory effects of vasoactive intestinal polypeptide and nitric oxide in canine fundusFailure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.YC-1 potentiates nitric oxide-induced relaxation in guinea-pig trachea.Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor.Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosisFM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation.Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodentsPathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclaseA new small molecule inhibitor of soluble guanylate cyclase.Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.Inhibition of inositol 1,4,5-trisphosphate-induced Ca2+ release by cAMP-dependent protein kinase in a living cell.Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase.
P2860
Q22306368-C6387478-C440-4F45-8F41-6C89B103B8D3Q24312335-29037BBF-CA9A-4060-A3A6-55B43998AEB8Q24630263-7202B5CE-AE44-43FE-998E-3068633E5D1EQ26752401-B6FDA4AD-F07E-424F-A304-B83832D80635Q26771830-6B9EA6BD-1BF7-4AE5-838D-1B40B56C50A2Q28193055-BF476917-767C-45AB-8082-F0A93729F4A7Q28193679-ECFA91BD-90BB-4DC0-935F-E1AF8CDFB99FQ28210282-3B1DB63B-53AA-42BD-83C0-388227A7ED8BQ28343439-38F14998-FBA0-462E-B8CF-6972C772A85FQ28345869-E0F8C9C5-141C-4F17-82D5-5A66F78F3A0FQ28363017-B2A6B110-6C68-4089-8189-87B2615D4CA6Q28363811-6FBE528B-37BA-4D6E-A2AA-4477F88A8664Q28543697-AB2AD160-60E3-4765-A886-AEC14C015D8CQ28578483-5D57B793-B3EC-434A-B953-31030E5C1DE8Q28587552-1C16FFF6-BCE6-402F-8471-273DB5E61778Q32031575-647448E6-F90C-4F79-893F-E45ED37241D0Q33554184-271A401C-E23D-4B3A-9E91-492650360669Q33630333-37004C67-643A-48DE-99C2-C6DA4DDEFF54Q33775475-84C56C2B-6A44-4F16-90E7-6BA667EB2A15Q33928520-18C94CC8-3ED3-4264-B258-B7AB379B1B77Q34291742-4C9DEDBA-E595-498C-892D-5231AC98E31BQ34430046-3CF98CEF-D929-4397-B81F-378A41A69114Q34535638-8535F0D8-32C9-48A6-874D-ADAE92685637Q34973811-2776CE66-E7D5-4E78-AF26-287464D66322Q35028665-F7E9E5F3-242E-4627-A4A0-1C5054F35362Q35028967-7BD46DDE-8C42-48E6-B167-C43D43F2F27BQ35041586-C6492C08-0FC4-4DBD-BE79-3CBB17FD7784Q35042778-C5310A36-BD6F-4091-BD3E-AFF2B5AC8096Q35044777-DDB4FD43-72C7-429A-B184-B8F2E1D3CA78Q35048911-75AEB1AA-79D0-46D2-96BF-51EE1B3F05F5Q35111461-9A6C46BE-FD58-44DF-8D61-49D8D8196E6FQ35141164-77B09C3D-276C-434F-9545-11688AE8B962Q35164124-CA4B490F-D73A-456C-A245-F62F77268BDBQ35266258-A357266B-28ED-4990-A076-39110EC6DF93Q35737682-E39393CD-E2C1-4D86-BCE9-8A258962ED0DQ35743176-A71B8DA0-4DAC-4EC6-8E1D-5B6908E2871DQ35824102-ADF4A266-0942-4E36-A59D-29DCF9E1C678Q35876629-6BF313EE-902E-4EFE-A3D5-2768B0B451CFQ35934127-B8F7E54D-1E84-448D-97C8-8D4E1CED01BCQ36058741-D2214719-5DAA-4685-B2E3-30D4CD809B03
P2860
cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
cGMP mediates the vascular and ...... the soluble guanylyl cyclase.
@en
cGMP mediates the vascular and ...... the soluble guanylyl cyclase.
@nl
type
label
cGMP mediates the vascular and ...... the soluble guanylyl cyclase.
@en
cGMP mediates the vascular and ...... the soluble guanylyl cyclase.
@nl
prefLabel
cGMP mediates the vascular and ...... the soluble guanylyl cyclase.
@en
cGMP mediates the vascular and ...... the soluble guanylyl cyclase.
@nl
P2093
P2860
P50
P356
P1476
cGMP mediates the vascular and ...... f the soluble guanylyl cyclase
@en
P2093
M W Radomski
R J Russel
V M Darley-Usmar
P2860
P304
P356
10.1073/PNAS.93.4.1480
P407
P577
1996-02-01T00:00:00Z